News Article
Chemours Commends the European Patent Office for Upholding Solstice’s HFO-1234yf Process Patent
The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company, applauds the decision by the Boards of Appeal of the European Patent Office to uphold European Patent EP 2546225, which protects HFO‑1234yf manufacturing processes.
Read More